Analytical Development and Quality Control Co-op jobs in United States
cer-icon
Apply on Employer Site
company-logo

PepGen · 19 hours ago

Analytical Development and Quality Control Co-op

PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies. The Analytical Development and Quality Control Co-op will support key aspects of the Chemistry, Manufacturing, and Controls program of PepGen’s current pipeline product candidates.

BiotechnologyClinical TrialsMedical
check
H1B Sponsor Likelynote

Responsibilities

Assist intermediate, drug substance and drug product impurity characterization
Support method robustness assessment of LC-MS methods for intermediate and drug substance
Support phase-appropriate impurity HPLC analytical method development/optimization

Qualification

HPLCMass spectrometryProtein/peptide experienceNucleic acids experienceCommunication skills

Required

Pursuing a BS or MS in Chemistry, Biochemistry, Biotechnology, or a closely related field
Excellent communication skills, both oral and written
Ability to work onsite Monday – Friday in the Boston office

Preferred

Experience working with proteins/peptides and nucleic acids a plus
Hands-on experience with HPLC and mass spectrometer instrumentation and data interpretation a plus

Benefits

Paid federal holidays
Sick time
A fully subsidized MBTA pass

Company

PepGen

twittertwittertwitter
company-logo
PepGen is empowering nucleic acid therapeutics to go the distance.

H1B Sponsorship

PepGen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2023 (1)
2022 (2)

Funding

Current Stage
Public Company
Total Funding
$354.68M
Key Investors
RA Capital Management
2025-09-24Post Ipo Equity· $115M
2024-02-07Post Ipo Equity· $80.1M
2022-05-06IPO

Leadership Team

leader-logo
James McArthur
Chief Executive Officer
linkedin
leader-logo
Hayley Parker
Senior Vice President
linkedin
Company data provided by crunchbase